Association Between Event-Free Survival and Overall Survival in Early-Stage Triple-Negative Breast Cancer

Min Huang1 Merck & Co., Inc., Rahway, NJ, USACorrespondence[email protected]

Peter A Fasching2 Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Department of Gynecology & Obstetrics, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

Amin Haiderali1 Merck & Co., Inc., Rahway, NJ, USA

https://orcid.org/0000-0002-6858-1564

Weiguang Xue3 Analysis Group, London, UK

https://orcid.org/0000-0003-0713-2869

Wilbur Pan1 Merck & Co., Inc., Rahway, NJ, USA

Vassiliki Karantza1 Merck & Co., Inc., Rahway, NJ, USA

Fan Yang3 Analysis Group, London, UK

James Truscott3 Analysis Group, London, UK

Yiqiao Xin3 Analysis Group, London, UK

Joyce O’Shaughnessy4 Baylor University Medical Center, Texas Oncology & US Oncology, Dallas, TX, USA

show all

Association Between Event-Free Survival and Overall Survival in Early-Stage Triple-Negative Breast Cancer

Supplemental Text 1

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Association Between Event-Free Survival and Overall Survival in Early-Stage Triple-Negative Breast Cancer

Supplemental Text 1

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date